口腔黏膜相关疾病免疫功能检测及意义

doi:10.12016/j.issn.2096-1456.2021.02.001

口腔疾病防治 ›› 2021, Vol. 29 ›› Issue (2): 73-80.DOI: 10.12016/j.issn.2096-1456.2021.02.001

口腔黏膜相关疾病免疫功能检测及意义

王安训()

中山大学附属第一医院口腔颌面外科, 广东广州（510080）

收稿日期:2020-02-09 修回日期:2020-04-25 出版日期:2021-02-20 发布日期:2020-12-21
通讯作者: 王安训
作者简介:王安训,1993 年毕业于中山医科大学口腔系,2001年毕业于中山医科大学肿瘤学专业,获博士学位,现任中山大学附属第一医院口腔颌面外科教授、博士生导师。兼任广东省口腔医学会口腔颌面外科专业委员会副主任委员、中国抗癌协会肿瘤微创外科治疗专业委员会副主任委员。主要从事口腔颌面部肿瘤的临床及基础研究,致力于提高早期预测口腔鳞癌的侵袭转移能力以及提高口腔鳞癌疗效的研究。目前已公开发表学术论文170 余篇,其中 SCI 论文 70 余篇。培养的多名研究生获得广东省优秀研究生和优秀研究生论文。负责多项国家级及省部级基金资助项目研究,包括教育部新世纪优秀人才支持计划、国家自然科学基金面上项目、广东省自然科学基金重点项目等。主编并编写了多本口腔医学专业著作,包括《口腔疾病》（副主编,科学技术文献出版社）、《牙槽外科手术视听教材》（主编,人民卫生电子音像出版社,“十五”国家重点音像出版规划）等。获教育部提名国家科技进步奖二等奖。
基金资助:
国家自然科学基金项目(NSFC81672659);广东省自然科学基金面上项目(2020A1515010291)

Detection and significance of immune function in oral mucosa-associated diseases

WANG Anxun()

Department of Oral and Maxillofacial Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China

Received:2020-02-09 Revised:2020-04-25 Online:2021-02-20 Published:2020-12-21
Contact: Anxun WANG
Supported by:
grants from National Nature Science Foundation of China(NSFC81672659);Guangdong Basic and Applied Basic Research Foundation(2020A1515010291)

摘要/Abstract

摘要：

免疫功能的评估在多种疾病的诊断、治疗和预后评估中具有重要作用,目前常用的免疫功能检测包括细胞免疫、体液免疫以及炎症标志物等。本文首先讨论免疫功能及其检测在各种疾病诊断、鉴别诊断、治疗监测中的应用状况;然后结合文献资料和笔者课题组的研究,阐述免疫功能检测在3种常见口腔黏膜相关疾病诊断和治疗中的应用价值,包括复发性阿弗他溃疡（recurrent aphthous ulcer, RAU）、口腔扁平苔藓（oral lichen planus, OLP）以及口腔鳞状细胞癌（oral squamous cell carcinoma, OSCC）。笔者研究发现RAU患者呈现体液免疫功能异常和明显的炎症反应,OLP和OSCC患者呈现轻度的炎症反应和更为严重的细胞免疫功能和体液免疫功能的异常。由此可见免疫功能的联合检测对这些疾病的诊断和治疗具有一定的指导价值,但未来还必须开展大样本、多中心、多指标联合检测的研究,从而更加完善地阐明免疫功能异常在各种疾病发病中的作用及其机理,建立相应的诊断模型和预后预测模型,同时寻找更为有效的治疗手段。

关键词: 复发性阿弗他溃疡, 扁平苔藓, 口腔鳞状细胞癌, 口腔黏膜, 免疫功能, 淋巴细胞亚群, 细胞免疫, 体液免疫, 炎症, 生物标志物

Abstract:

The evaluation of immune function plays an important role in the diagnosis, treatment and prognosis of many diseases. To date, immune function detection includes cellular immunity, humoral immunity, and inflammatory markers. In this paper, the application of immune function detection in the diagnosis, differential diagnosis and treatment monitoring of various diseases was discussed; then, the application value of immune function detection in the diagnosis and treatment of three common oral mucosa-related diseases, including recurrent aphthous ulcer (RAU), oral lichen planus (OLP), and oral squamous cell carcinoma (OSCC), were reviewed combined with the literature and our research. Our research found that RAU patients present abnormal humoral immune function and obvious inflammatory reactions, whereas OLP and OSCC patients present mild inflammatory reactions and more serious abnormal cellular and humoral immune function, so the combined detection of immune function has a certain guiding value for the diagnosis and treatment of these diseases. Moreover, in the future, it is necessary to carry out a study on large sample, multicenter and multiindex joint detection to better clarify the role of immune dysfunction in the pathogenesis of various diseases and its mechanism, to establish the corresponding diagnostic model and prognostic prediction model, to find more effective treatment methods.

Key words: recurrent aphthous ulcer, lichen planus, oral squamous cell carcinoma, oral mucosa, immunity, lymphocyte subsets, cellular immunity, humoral immunity, inflammation, biomarkers

中图分类号:

R781.5

王安训. 口腔黏膜相关疾病免疫功能检测及意义[J]. 口腔疾病防治, 2021, 29(2): 73-80.

WANG Anxun. Detection and significance of immune function in oral mucosa-associated diseases[J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(2): 73-80.

参考文献 33

[1]	Xiong W, Liu ZG, Xiong L, et al. CD3(+), CD4(+), and CD8(+) expression in cells in peripheral blood of silicosis patients and intervention effect of thymalfasin[J]. Ann Clin Lab Sci, 2019,49(3):368-371. URL PMID
[2]	Levite M. Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases[J]. Acta Physiol (Oxf), 2016,216(1):42-89. doi: 10.1111/apha.12476. DOI URL
[3]	Kanellopoulos JM, Ojcius DM. Development of humoral immunity[J]. Biomed J, 2019,42(4):207-208. doi: 10.1016/j.bj.2019.08.003. DOI URL PMID
[4]	Shah NN, Maatman T, Hari P, et al. Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies[J]. Front Oncol, 2019,9:146. doi: 10.3389/fonc.2019.00146. DOI URL PMID
[5]	Chen K, Magri G, Grasset EK, et al. Rethinking mucosal antibody responses: IgM, IgG and IgD join IgA[J]. Nat Rev Immunol, 2020. doi: 10.1038/s41577-019-0261-1. DOI URL PMID
[6]	Peppas I, George G, Sollie S, et al. Association of serum immunoglobulin levels with solid cancer: a systematic review and meta-analysis[J]. Cancer Epidemiol Biomarkers Prev, 2020,29(3):527-538. doi: 10.1158/1055-9965. DOI URL PMID
[7]	de Taeye SW, Rispens T, Vidarsson G. The ligands for human IgG and their effector functions[J]. Antibodies (Basel), 2019,8(2):30. doi: 10.3390/antib8020030.
[8]	Kubo K, Yamamoto K. IgG4-related disease[J]. Int J Rheum Dis, 2016,19(8):747-762. doi: 10.1111/1756-185X.12586. DOI URL PMID
[9]	Liu J, Wang Y, Xiong E, et al. Role of the IgM Fc receptor in immunity and tolerance[J]. Front Immunol, 2019,10:529. doi: 10.3389/fimmu.2019.00529. DOI URL PMID
[10]	Li Y, Jin L, Chen T. The effects of secretory IgA in the mucosal immune system[J]. Biomed Res Int, 2020,2020:2032057. doi: 10.1155/2020/2032057. DOI URL PMID
[11]	Bunker JJ, Bendelac A. IgA responses to microbiota[J]. Immunity 2018,49(2):211-224. doi: 10.1016/j.immuni.2018.08.011. DOI URL PMID
[12]	Sala P, Colatutto A, Fabbro D, et al. Immunoglobulin K light chain deficiency: a rare, but probably underestimated, humoral immune defect[J]. Eur J Med Genet, 2016,59(4):219-222. doi: 10.1016/j.ejmg.2016.02.003. DOI URL PMID
[13]	Li Q, Lu Q, Zhu MQ, et al. Lower level of complement component C3 and C3a in the plasma means poor outcome in the patients with hepatitis B virus related acute-on-chronic liver failure[J]. BMC Gastroenterol, 2020,20(1):106. doi: 10.1186/s12876-020-01258-3. DOI URL PMID
[14]	Zhang L, Qiao Z, Feng H, et al. The early predictive role of complement C3 and C4 in patients with acute pancreatitis[J]. J Clin Lab Anal, 2020: e23205. doi: 10.1002/jcla.23205.
[15]	Germolec DR, Shipkowski KA, Frawley RP, et al. Markers of inflammation[J]. Methods Mol Biol, 2018,1803:57-79. doi: 10.1007/978-1-4939-8549-4_5. DOI URL PMID
[16]	Matowicka-Karna J. Markers of inflammation, activation of blood platelets and coagulation disorders in inflammatory bowel diseases[J]. Postepy Hig Med Dosw (Online), 2016,70:305-312. doi: 10.5604/17322693.1199305. DOI URL
[17]	Dima A, Opris D, Jurcut C, et al. Is there still a place for erythrocyte sedimentation rate and C-reactive protein in systemic lupus erythematosus?[J]. Lupus, 2016,25(11):1173-1179. doi: 10.1177/0961203316651742. DOI URL PMID
[18]	Swiatkiewicz I, Taub PR. The usefulness of C-reactive protein for the prediction of post-infarct left ventricular systolic dysfunction and heart failure[J]. Kardiol Pol, 2018,76(5):821-829. doi: 10.5603/KP.a2018.0091. DOI URL PMID
	Swiatkiewicz I, Taub PR. The usefulness of C-reactive protein for the prediction of post-infarct left ventricular systolic dysfunction and heart failure[J]. Kardiol Pol, 2018,76(5):821-829. doi: 10.5603/KP.a2018.0091. DOI URL PMID
[19]	Formiga MF, Vital I, Urdaneta G, et al. Higher serum levels of systemic inflammatory markers are linked to greater inspiratory muscle dysfunction in COPD[J]. Clin Respir J, 2019,13(4):247-255. doi: 10.1111/crj.13006. DOI URL PMID
	Formiga MF, Vital I, Urdaneta G, et al. Higher serum levels of systemic inflammatory markers are linked to greater inspiratory muscle dysfunction in COPD[J]. Clin Respir J, 2019,13(4):247-255. doi: 10.1111/crj.13006. DOI URL PMID
[20]	Perez L. Acute phase protein response to viral infection and vaccination[J]. Arch Biochem Biophys, 2019,671:196-202. doi: 10.1016/j.abb.2019.07.013. DOI URL PMID
	Perez L. Acute phase protein response to viral infection and vaccination[J]. Arch Biochem Biophys, 2019,671:196-202. doi: 10.1016/j.abb.2019.07.013. DOI URL PMID
[21]	Sack GH, Jr. Serum amyloid A (SAA) proteins[J]. Subcell Biochem, 2020,94:421-436. doi: 10.1007/978-3-030-41769-7_17. DOI URL PMID
	Sack GH, Jr. Serum amyloid A (SAA) proteins[J]. Subcell Biochem, 2020,94:421-436. doi: 10.1007/978-3-030-41769-7_17. DOI URL PMID
[22]	江南, 罗亮, 刘莉, 等. 复发性阿弗他溃疡患者可溶性程序性死亡受体1及可溶性程序性死亡配体1表达与免疫功能的相关性[J]. 华西口腔医学杂志, 2017,35(3):286-290. doi: 10.7518/hxkq.2017.03.011.
	江南, 罗亮, 刘莉, 等. 复发性阿弗他溃疡患者可溶性程序性死亡受体1及可溶性程序性死亡配体1表达与免疫功能的相关性[J]. 华西口腔医学杂志, 2017,35(3):286-290. doi: 10.7518/hxkq.2017.03.011.
	Jiang N, Luo L, Liu L, et al. Soluble programmed death-1 and soluble programmed death ligand 1 protein expression and immune status in patients with recurrent aphthous ulcer[J]. West Chin J Stomatol, 2017,35(3):286-290. doi: 10.7518/hxkq.2017.03.011.
	Jiang N, Luo L, Liu L, et al. Soluble programmed death-1 and soluble programmed death ligand 1 protein expression and immune status in patients with recurrent aphthous ulcer[J]. West Chin J Stomatol, 2017,35(3):286-290. doi: 10.7518/hxkq.2017.03.011.
[23]	邹俐琳, 王文梅, 刘雅菁, 等. 顽固性复发性阿弗他溃疡患者外周血Th17细胞与免疫球蛋白及补体水平的变化[J]. 上海口腔医学, 2017,26(5):521-525. doi: 10.19439/j.sjos.2017.05.011. URL PMID
	邹俐琳, 王文梅, 刘雅菁, 等. 顽固性复发性阿弗他溃疡患者外周血Th17细胞与免疫球蛋白及补体水平的变化[J]. 上海口腔医学, 2017,26(5):521-525. doi: 10.19439/j.sjos.2017.05.011. URL PMID
	Zou LL, Wang WM, Liu YJ, et al. Alteration of Th17 cells, immunoglobins and complements levels in peripheral blood of patients with refractory recurrent aphthous ulcer[J]. Shanghai Kou Qiang Yi Xue, 2017,26(5):521-525. doi: 10.19439/j.sjos.2017.05.011. URL PMID
	Zou LL, Wang WM, Liu YJ, et al. Alteration of Th17 cells, immunoglobins and complements levels in peripheral blood of patients with refractory recurrent aphthous ulcer[J]. Shanghai Kou Qiang Yi Xue, 2017,26(5):521-525. doi: 10.19439/j.sjos.2017.05.011. URL PMID
[24]	Koridze K, Ladashvili L, Taboridze I, et al. Immunological aspects of aphthous stomatitis[J]. Georgian Med News, 2007, (151):37-39. URL PMID
	Koridze K, Ladashvili L, Taboridze I, et al. Immunological aspects of aphthous stomatitis[J]. Georgian Med News, 2007, (151):37-39. URL PMID
[25]	Sun A, Chu CT, Liu BY, et al. Expression of interleukin-2 receptor by activated peripheral blood lymphocytes upregulated by the plasma level of interleukin-2 in patients with recurrent aphthous ulcers[J]. Proc Natl Sci Counc Repub China B, 2000,24(3):116-122. URL PMID
	Sun A, Chu CT, Liu BY, et al. Expression of interleukin-2 receptor by activated peripheral blood lymphocytes upregulated by the plasma level of interleukin-2 in patients with recurrent aphthous ulcers[J]. Proc Natl Sci Counc Repub China B, 2000,24(3):116-122. URL PMID
[26]	Atas H, Cemil BC, Kurmus GI, et al. Assessment of systemic inflammation with neutrophil-lymphocyte ratio in lichen planus[J]. Postepy Dermatol Alergol, 2016,33(3):188-192. doi: 10.5114/pdia.2016.56930. DOI URL PMID
	Atas H, Cemil BC, Kurmus GI, et al. Assessment of systemic inflammation with neutrophil-lymphocyte ratio in lichen planus[J]. Postepy Dermatol Alergol, 2016,33(3):188-192. doi: 10.5114/pdia.2016.56930. DOI URL PMID
[27]	黄韵颖, 周塑, 蔡扬. 口腔扁平苔藓患者血清中白细胞介素-12和白细胞介素-27表达与免疫功能的相关性口腔扁平苔藓患者血清中白细胞介素-12和白细胞介素-27表达与免疫功能的相关性[J]. 华西口腔医学杂志, 2016,34(2):140-144. doi: 10.7518/hxkq.2016.02.007. DOI URL
	黄韵颖, 周塑, 蔡扬. 口腔扁平苔藓患者血清中白细胞介素-12和白细胞介素-27表达与免疫功能的相关性口腔扁平苔藓患者血清中白细胞介素-12和白细胞介素-27表达与免疫功能的相关性[J]. 华西口腔医学杂志, 2016,34(2):140-144. doi: 10.7518/hxkq.2016.02.007. DOI URL
	Huang YY, Zhou S, Cai Y. Expression of interleukin-12 and interleukin-27 proteins and immune status in serum of patients with oral lichen planus[J]. West Chin J Stomatol, 2016,34(2):140-144. doi: 10.7518/hxkq.2016.02.007. DOI URL
	Huang YY, Zhou S, Cai Y. Expression of interleukin-12 and interleukin-27 proteins and immune status in serum of patients with oral lichen planus[J]. West Chin J Stomatol, 2016,34(2):140-144. doi: 10.7518/hxkq.2016.02.007. DOI URL
[28]	Biocina-Lukenda D, Cekic-Arambasin A, Markeljevic J, et al. Serum immunoglobulins IgG, IgA and IgM in patients with oral lichen ruber[J]. Coll Antropol, 2008,32(1):161-163. URL PMID
	Biocina-Lukenda D, Cekic-Arambasin A, Markeljevic J, et al. Serum immunoglobulins IgG, IgA and IgM in patients with oral lichen ruber[J]. Coll Antropol, 2008,32(1):161-163. URL PMID
[29]	Grimm M, Feyen O, Hofmann H, et al. Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue[J]. Tumour Biol, 2016,37(3):3807-3816. doi: 10.1007/s13277-015-4224-2. DOI URL PMID
	Grimm M, Feyen O, Hofmann H, et al. Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue[J]. Tumour Biol, 2016,37(3):3807-3816. doi: 10.1007/s13277-015-4224-2. DOI URL PMID
[30]	Bose A, Chakraborty T, Chakraborty K, et al. Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients[J]. Cancer Immun, 2008,8:10. URL PMID
	Bose A, Chakraborty T, Chakraborty K, et al. Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients[J]. Cancer Immun, 2008,8:10. URL PMID
[31]	Rajendran R, Sugathan CK, Remani P, et al. Cell mediated and humoral immune responses in oral submucous fibrosis[J]. Cancer, 1986,58(12):2628-2631. doi: 10.1002/1097-0142(19861215)58:12<2628::aid-cncr2820581214>3.0.co;2-z. DOI URL PMID
	Rajendran R, Sugathan CK, Remani P, et al. Cell mediated and humoral immune responses in oral submucous fibrosis[J]. Cancer, 1986,58(12):2628-2631. doi: 10.1002/1097-0142(19861215)58:12<2628::aid-cncr2820581214>3.0.co;2-z. DOI URL PMID
[32]	DE Paz D, Young CK, Chien HT, et al. Prognostic roles of SCC antigen, CRP and CYFRA 21-1 in oral cavity squamous cell carcinoma[J]. Anticancer Res, 2019,39(4):2025-2033. doi: 10.21873/anticanres.13313. DOI URL PMID
	DE Paz D, Young CK, Chien HT, et al. Prognostic roles of SCC antigen, CRP and CYFRA 21-1 in oral cavity squamous cell carcinoma[J]. Anticancer Res, 2019,39(4):2025-2033. doi: 10.21873/anticanres.13313. DOI URL PMID
[33]	Du J, Hu W, Yang C, et al. C-reactive protein is associated with the development of tongue squamous cell carcinoma[J]. Acta Biochim Biophys Sin (Shanghai), 2018,50(3):238-245. doi: 10.1093/abbs/gmy004. DOI URL
	Du J, Hu W, Yang C, et al. C-reactive protein is associated with the development of tongue squamous cell carcinoma[J]. Acta Biochim Biophys Sin (Shanghai), 2018,50(3):238-245. doi: 10.1093/abbs/gmy004. DOI URL

口腔黏膜相关疾病免疫功能检测及意义

Detection and significance of immune function in oral mucosa-associated diseases

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 33

相关文章 15

编辑推荐

Metrics

[1]	张琳,唐雅文,王建涛,王艳. 益生菌防治口腔和胃肠道放化疗黏膜炎的研究进展[J]. 口腔疾病防治, 2021, 29(8): 567-571.
[2]	王承煜,范亚伟,王珏. 富血小板纤维蛋白与脱细胞真皮基质修复兔口腔黏膜缺损效果比较[J]. 口腔疾病防治, 2021, 29(7): 442-448.
[3]	单超,王婷婷,赵今. 白细胞介素-18与慢性牙周炎相关性的研究进展[J]. 口腔疾病防治, 2021, 29(7): 485-489.
[4]	李明,南欣荣,原振英,唐瞻贵. 磁共振成像评估舌鳞状细胞癌浸润深度的准确性分析[J]. 口腔疾病防治, 2021, 29(5): 322-327.
[5]	顾雯佳,陆海霞,张羽,冯希平. 牙周炎与消化系统癌症相关性研究进展[J]. 口腔疾病防治, 2021, 29(5): 346-350.
[6]	翦新春,高兴. 口腔黏膜下纤维性变的病因、致病机理、诊断与治疗[J]. 口腔疾病防治, 2021, 29(4): 217-225.
[7]	凌云霄,王建涛,王艳. 放化疗性口腔黏膜炎相关生物标志物研究进展[J]. 口腔疾病防治, 2021, 29(4): 260-266.
[8]	王紫莹,陈晓涛. 辅助性T细胞17与白细胞介素17在口腔黏膜疾病中的研究进展[J]. 口腔疾病防治, 2021, 29(3): 194-197.
[9]	林琳,吴开慧,王文梅. 氯喹/羟氯喹的作用机制及其在口腔疾病中的应用[J]. 口腔疾病防治, 2021, 29(3): 198-201.
[10]	潘英潇,郭大伟,李新,卢恕来. 口腔扁平苔藓相关microRNAs的研究进展[J]. 口腔疾病防治, 2021, 29(3): 206-210.
[11]	时洋洋,周学东,程磊,任彪. 白色念珠菌感染与口腔癌的关系[J]. 口腔疾病防治, 2021, 29(2): 119-123.
[12]	嵇灵,王甲河,王建涛,王艳. Toll样受体在放化疗诱导的消化道黏膜炎中的作用[J]. 口腔疾病防治, 2021, 29(2): 124-129.
[13]	吴泽钰,赵今,王琛,龚怡,薛瑞. 网络药理学探索雷公藤治疗口腔扁平苔藓的药理特性和治疗机制[J]. 口腔疾病防治, 2021, 29(12): 809-819.
[14]	张倩,陈斌,闫福华. 牙周基础治疗后龈沟液中4种生物标志物水平变化及临床意义[J]. 口腔疾病防治, 2021, 29(12): 828-835.
[15]	肖婷,唐瞻贵. 治疗口腔黏膜下纤维性变常用中药和西药的研究进展[J]. 口腔疾病防治, 2021, 29(11): 771-775.